Stay updated on Dupilumab for Eosinophilic Gastritis Clinical Trial
Sign up to get notified when there's something new on the Dupilumab for Eosinophilic Gastritis Clinical Trial page.

Latest updates to the Dupilumab for Eosinophilic Gastritis Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check19 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check26 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check55 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check62 days agoChange DetectedThe page has undergone significant updates, including the removal of detailed study protocol information for a clinical trial on Eosinophilic Gastritis and the addition of collaborators and a revision number. Notably, the specific details about participant criteria and treatment regimens have been deleted.SummaryDifference30%
Stay in the know with updates to Dupilumab for Eosinophilic Gastritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab for Eosinophilic Gastritis Clinical Trial page.